Novel Technologies for Investigation of Self-reactive T cells in MS and Relevant

研究多发性硬化症及相关疾病中自身反应性 T 细胞的新技术

基本信息

  • 批准号:
    8583040
  • 负责人:
  • 金额:
    $ 21.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-01 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

This core will make important resources available to all Projects of this PPG. The nanowell technology represents a powerful tool to study the functional consequences of interactions between T cells and APC. The technology will enable in-depth investigation of the impact of different types of APCs on the functional programs of self-reactive T cells, which is of central importance to this PPG. A novel feature of this technology is that the functional consequences on both T cells and APC can be studied for interacting cell pairs, offering insights into the complex communication that programs self-reactive T cells with autoaggressive behavior. This core will enable integration of datasets from clinical specimens and experimental mouse models (Aim 1). It provides an important link between Projects 1 and 2, which both study myelin-specific T cells from patients with MS. The technology enables robotic isolation of cells of interest, such as myelin-specific T cells that produce combinations of pro-inflammatory cytokines (e.g. IL-17 + GM-CSF), for analysis of single-cell gene expression or clonal expansion. Furthermore, the technology will be made available for analysis of murine T cells, APCs and stromal cells (Projects 3 and 4). The core will also make recombinant proteins available to all Projects of this PPG, including experiments in the nanowell system (Aim 2), This core has provided such reagents to all Projects in the previous funding period and will continue to provide them for several efforts: 1. Studies by Dustin and Wucherpfennig have examined immunological synapse formation by human self-reactive T cells using the planar lipid bilayer system developed by the Dustin lab. Recent collaborative studies by the Love and Wucherpfennig labs have applied this approach to the nanowell system, enabling synapse structure to be related tp T cell function. These experiments require sets of human and murine recombinant proteins, including peptide-MHC complexes, ICAM-1 and CD80 (Projects 1 and 2). 2. Collaborative studies by the Kuchroo and Wucherpfennig labs have shown that tetramers of the MOG extracellular domain can be used to label MOG-specific B cells, and this reagent will be used in Project 3. 3. The turley, Kuchroo and Wucherpfennig labs have utilized Ig fusion proteins of podoplanin and CLEC-2 to study the function of these molecules in T cell - APC communication, which will be provided to Projects 3 and 4. This core will thus enable in-depth investigation of T cell - APC interactions in both humans and animal models to advance our understanding ofthe pathogenesis of MS.
该核心将为PPG的所有项目提供重要资源。纳米井技术

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIJAY K. KUCHROO其他文献

VIJAY K. KUCHROO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIJAY K. KUCHROO', 18)}}的其他基金

Metabolic regulators of Treg/Th17 balance in CNS autoimmunity
CNS 自身免疫中 Treg/Th17 平衡的代谢调节因子
  • 批准号:
    10708996
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity
CNS 自身免疫中 Treg/Th17 平衡的代谢调节因子
  • 批准号:
    10585009
  • 财政年份:
    2022
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
Tim-3:Bat-3 通路在诱导耐受性 DC 和外周耐受中的作用
  • 批准号:
    10333307
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
项目 4:在胶质母细胞瘤中诱导 T 细胞功能障碍的触发因素
  • 批准号:
    10477988
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
Tim-3:Bat-3 通路在诱导耐受性 DC 和外周耐受中的作用
  • 批准号:
    10094188
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
Tim-3:Bat-3 通路在诱导耐受性 DC 和外周耐受中的作用
  • 批准号:
    9887786
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
项目 4:在胶质母细胞瘤中诱导 T 细胞功能障碍的触发因素
  • 批准号:
    10684037
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
项目 4:在胶质母细胞瘤中诱导 T 细胞功能障碍的触发因素
  • 批准号:
    10210223
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance
Tim-3:Bat-3 通路在诱导耐受性 DC 和外周耐受中的作用
  • 批准号:
    10551198
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
Role of Tim-1 and Bregs in Tolerance and Autoimmunity
Tim-1 和 Bregs 在耐受性和自身免疫中的作用
  • 批准号:
    10455068
  • 财政年份:
    2018
  • 资助金额:
    $ 21.74万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了